243 related articles for article (PubMed ID: 26774689)
1. Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): A retrospective case series and cohort study.
Kessels J; Hendriks J; Nelemans P; Mosterd K; Kelleners-Smeets N
J Am Acad Dermatol; 2016 May; 74(5):899-906. PubMed ID: 26774689
[TBL] [Abstract][Full Text] [Related]
2. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
[TBL] [Abstract][Full Text] [Related]
3. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
4. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
5. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.
de Haas ER; Kruijt B; Sterenborg HJ; Martino Neumann HA; Robinson DJ
J Invest Dermatol; 2006 Dec; 126(12):2679-86. PubMed ID: 16841035
[TBL] [Abstract][Full Text] [Related]
6. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
8. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial.
Kessels JPHM; Kreukels H; Nelemans PJ; Roozeboom MH; van Pelt H; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Br J Dermatol; 2018 May; 178(5):1056-1063. PubMed ID: 28886209
[TBL] [Abstract][Full Text] [Related]
9. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers.
Tarstedt M; Gillstedt M; Wennberg Larkö AM; Paoli J
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):420-3. PubMed ID: 26841041
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma.
van Delft LCJ; Nelemans PJ; Kessels JPHM; Kreukels H; Roozeboom MH; de Rooij MJM; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Dermatology; 2022; 238(6):1044-1049. PubMed ID: 35598594
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial.
Roozeboom MH; Nelemans PJ; Mosterd K; Steijlen PM; Arits AH; Kelleners-Smeets NW
Br J Dermatol; 2015 Mar; 172(3):739-45. PubMed ID: 25066012
[TBL] [Abstract][Full Text] [Related]
13. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836
[TBL] [Abstract][Full Text] [Related]
14. 5-aminolevulinic acid based photodynamic therapy for basal cell carcinoma: a 10-years follow-up study.
Griškjans Ž; Derjabo A; Čēma I
Stomatologija; 2013; 15(1):32-6. PubMed ID: 23732828
[TBL] [Abstract][Full Text] [Related]
15. Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up.
Star WM; van't Veen AJ; Robinson DJ; Munte K; de Haas ER; Sterenborg HJ
Acta Derm Venereol; 2006; 86(5):412-7. PubMed ID: 16955185
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy for cutaneous squamous cell carcinoma in situ: Impact of anatomic location, tumor diameter, and incubation time on effectiveness.
Kibbi N; Zhang Y; Leffell DJ; Christensen SR
J Am Acad Dermatol; 2020 May; 82(5):1124-1130. PubMed ID: 31712171
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma.
Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM
Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332
[TBL] [Abstract][Full Text] [Related]
18. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study.
Christensen E; Mørk C; Skogvoll E
Br J Dermatol; 2012 Jun; 166(6):1342-8. PubMed ID: 22309486
[TBL] [Abstract][Full Text] [Related]
19. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma.
Rhodes LE; de Rie MA; Leifsdottir R; Yu RC; Bachmann I; Goulden V; Wong GA; Richard MA; Anstey A; Wolf P
Arch Dermatol; 2007 Sep; 143(9):1131-6. PubMed ID: 17875873
[TBL] [Abstract][Full Text] [Related]
20. Treatment of superficial basal cell carcinoma with photodynamic therapy. Observational study in 22 patients with 5-aminolaevulinic acid and methyl aminolaevulinate.
Alique-García S; Company-Quiroga J; Sánchez Campos A; Hernández Núñez A; Borbujo J
Photodiagnosis Photodyn Ther; 2019 Jun; 26():190-192. PubMed ID: 30914392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
